Skip to main content

Pesicka Edward A's Form 4 filing

Accendra Health IncACH · filed Jun 12, 2023

Accession no.
0001062993-23-013351
Filed
Jun 12, 2023
Trade date
Jun 8-9, 2023
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions. Open-market sales total $4.99M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pesicka Edward ACIK 0001439487Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 8, 2023Common StockSSaleDisposed−118,928$21.19F2−$2,520,084.32904,861Direct
Jun 9, 2023Common StockSSaleDisposed−118,928$20.79F3−$2,472,513.12785,933Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Weighted average of the sale price range of $20.78 through $21.42

Referenced by the price of 1 transaction in Table I.

F3

Weighted average of the sale price range of $20.525 through $21.215

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)